Skip to content

ZENOBE

Active Public limited companyfounded 1993active for 33 yearsRue Grandgagnage 9, 4000 LiègeKBO/BCE: BE 0449.127.321

Lifetime

25 annual accounts with figures on one time axis, 33 filings since 1994
peak of €498,112 in 2024
-€15,793▼ €3,372
lowest -€376,784 in 2014
-€18,544▼ €16,553
peak of €651,097 in 2024
€571,205▼ 3.1%
-not published
peak of 8.8 FTE in 2014
-not published
Board4 names since 2012
4 directors and 3 others
Documentsfilings and deeds
05-10-202626 days before the deadline
2026micro format
Gross margin from -€12,421 to -€15,793Loss of €18,544

Key points

from the 2026 annual accounts

Losses

-€20,535 in two years
-1,9912025-18,5442026

The 2025 and 2026 financial years closed with a loss. 2026 was the heaviest.

Filings

33 annual accounts since 1994
deadline200020102020

Six of the last ten came late. The 2021 accounts came in latest, 26 days after the end of the period.

Turnover not published in the micro format

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 8,618 companies had the same profile as ZENOBE has now. Each dot stands for 22 companies, two years later.

94.2%
were still trading
5.1%
stopped another way
0.5%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a small loss

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 8,618 companies, not a prediction for ZENOBE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Chair
Director
Director
Director
  • 181,000 sharesdeed of 27-11-2020
  • 181,000 sharesdeed of 27-11-2020
Board & ownership

Recent changes

Registered office moved within Liège The registered office moved from Rue Louvrex 71/12 à 4000 Liège to Rue Grandgagnage 9 à 4000 Liège · General meeting of 20-09-2023 · Gazette deed
Demerger: GILLAM splits off to ZENOBE Capital increase of €54,128.99 to €278,026.67 · The capital rose from €223,897.68 to €278,026.67, with 181,000 new shares · , and reappointed · General meeting of 29-10-2020 · Gazette deed
Demerger proposal: ZENOBE splits off to GILLAM Gazette deed
Demerger proposal: GILLAM splits off to ZENOBE Gazette deed
All 61 events

Official details

Source: KBO
Status
Active since 18-01-1993Normal situation
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 2110001and 8 others9 activities on the establishment unitFrom the articles
Establishment unit
2.102.879.1334000 Liège, registered on 18-11-1999
Financial year end
31 March
Peppol
Not found in the Peppol Directory
Company details

Annual accounts to 31-03-2026

€571,205▼ 3.4%
Filing
Filed on 05-10-2026, 26 days before the end of the filing period
Financials

Insights on ZENOBE

ZENOBE files the micro format. That format states no turnover. The gross margin fell from €11,433 in 2007 to -€15,793 in 2026.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ZENOBE

What is the company number of ZENOBE?
The company number of ZENOBE is 0449.127.321. The VAT number is the same number with BE in front: BE 0449.127.321.
Where is ZENOBE based?
The registered office is at Rue Grandgagnage 9, 4000 Liège.Company details
What does ZENOBE do?
According to the KBO register, the main activity of the establishment unit is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 2110001). The KBO lists 8 more.
What is the legal form of ZENOBE?
ZENOBE is a public limited company (NV).
When was ZENOBE founded?
ZENOBE was founded on 18-01-1993.
Is ZENOBE still active?
Yes, ZENOBE is an active enterprise in the KBO register.
What is the turnover of ZENOBE?
The annual accounts for financial year 2026 state no turnover. The micro format does not require it.Financials
Is ZENOBE profitable?
In financial year 2026, ZENOBE made a loss of €18,544.
Where can I find the annual accounts of ZENOBE?
ZENOBE filed 33 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of ZENOBE due?
ZENOBE must file the annual accounts for financial year 2027 by 31-10-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.